Headlining >>>

FDA’s continuing use of ‘black box’ for antidepressants ignores the harms of this warning | By STEPHEN SOUMERAI AND ROSS KOPPEL

SPONSOR CONTENT BY STAT PLUS

In-depth biopharma, business, and policy analysis at your fingertips… Read More STAT: First Opinion  |  2 September 2018